Strength
300 mg/1
Manufacturer
i3 Pharmaceuticals, LLCNDC
72319002502
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
MARAVIROCApproval Type
Generic (ANDA)
FDA Application
ANDA217114On Market Since
9/15/2023
Pharmacological Classes
CCR5 Co-receptor Antagonist
Chemokine Co-receptor 5 Antagonists
Related Drugs
Same classification
No related drugs found.